OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
Judit Lazáry, Nóra Eszlári, Gabriella Juhász, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 716-722
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 106

Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 82

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Inés Gallego‐Landin, Alba García-Baos, Adriana Castro‐Zavala, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 52

Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 30

Meet Your Stress Management Professionals: The Endocannabinoids
Terri A. deRoon‐Cassini, Todd M. Stollenwerk, Margaret Beatka, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 953-968
Open Access | Times Cited: 49

Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear
Devon Michael Ivy, Francesca Palese, Valentina Vozella, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1330-1338
Open Access | Times Cited: 40

Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 26

Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders
Álvaro Morcuende, María S. García‐Gutiérrez, Simone Tambaro, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21

Lipid endocannabinoids in energy metabolism, stress and developmental programming
Mariana M. Almeida, Camilla P. Dias-Rocha, Camila Calviño, et al.
Molecular and Cellular Endocrinology (2021) Vol. 542, pp. 111522-111522
Closed Access | Times Cited: 24

Microglial cannabinoid receptor 2 and epigenetic regulation: implications for the treatment of depression
Priyanka Sharma, Rajni Daksh, Saumya Khanna, et al.
European Journal of Pharmacology (2025), pp. 177422-177422
Open Access

Mood, Motivation, and Mental Health
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 109-122
Closed Access

Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders
Arthur Alves Coelho, Sávio Lima-Bastos, Pedro H. Gobira, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 9

Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
Tahira Foyzun, M.J. Whiting, Kate K. Velasco, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2391-2412
Open Access | Times Cited: 2

Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression
Giuseppe Bersani, Francesca Pacitti, Angela Iannitelli, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 36, Iss. 4
Closed Access | Times Cited: 14

Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex
Taygun C. Uzuneser, Hanna J. Szkudlarek, Matthew Jones, et al.
Cerebral Cortex (2022) Vol. 33, Iss. 6, pp. 2470-2484
Open Access | Times Cited: 9

Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases
Leila Hosseinzadeh Anvar, Ali Ahmadalipour
BioFactors (2022) Vol. 49, Iss. 1, pp. 62-78
Closed Access | Times Cited: 7

An overview of major depression disorder: The endocannabinoid system as a potential target for therapy
Sergio Zarazúa, Jorge Genaro Vicente‐Martínez, Juan Manuel Pinos‐Rodríguez, et al.
Basic & Clinical Pharmacology & Toxicology (2024)
Open Access | Times Cited: 1

Genetic analyses of the endocannabinoid pathway in association with affective phenotypic variants
Judit Lazáry, Nóra Eszlári, Eszter Krikó, et al.
Neuroscience Letters (2021) Vol. 744, pp. 135600-135600
Open Access | Times Cited: 9

Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico–Striatal Loop That Are Implicated in Major Depression
Sari Goldstein Ferber, Aron Weller, Gal Yadid, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1867-1867
Open Access | Times Cited: 8

Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice
Haley A. Vecchiarelli, Robert J. Aukema, Catherine Hume, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 5

Anandamide and anxiety
Sara L. Kroll, Leah M. Mayo
Elsevier eBooks (2024), pp. 189-211
Closed Access

Page 1 - Next Page

Scroll to top